Cargando…

Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential

[Image: see text] A chemical inhibitor of antiapoptotic protein, BCL2, known as Disarib, suffers poor solubility in aqueous environments; thereby limiting its potential as a chemotherapeutic agent. To overcome this limitation and enhance the therapeutic efficacy of Disarib, we have employed the enca...

Descripción completa

Detalles Bibliográficos
Autores principales: Joy, Reshma, Siddiqua, Humaira, Sharma, Shivangi, Raveendran, Manthra, John, Franklin, Hassan, Puthusserickal Abdulrahiman, Gawali, Santosh L, Raghavan, Sathees C., George, Jinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621013/
https://www.ncbi.nlm.nih.gov/pubmed/37929147
http://dx.doi.org/10.1021/acsomega.3c05802
_version_ 1785130325625536512
author Joy, Reshma
Siddiqua, Humaira
Sharma, Shivangi
Raveendran, Manthra
John, Franklin
Hassan, Puthusserickal Abdulrahiman
Gawali, Santosh L
Raghavan, Sathees C.
George, Jinu
author_facet Joy, Reshma
Siddiqua, Humaira
Sharma, Shivangi
Raveendran, Manthra
John, Franklin
Hassan, Puthusserickal Abdulrahiman
Gawali, Santosh L
Raghavan, Sathees C.
George, Jinu
author_sort Joy, Reshma
collection PubMed
description [Image: see text] A chemical inhibitor of antiapoptotic protein, BCL2, known as Disarib, suffers poor solubility in aqueous environments; thereby limiting its potential as a chemotherapeutic agent. To overcome this limitation and enhance the therapeutic efficacy of Disarib, we have employed the encapsulation of this small molecule inhibitor within P123 copolymer matrix. Micelles were synthesized using a thin-film hydration technique, and a comprehensive analysis was undertaken to evaluate the resulting micelle properties, including morphology, particle size, intermolecular interactions, encapsulation efficiency, and in vitro release characteristics. This assessment utilized various physicochemical techniques including UV spectroscopy, FTIR spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), and small-angle X-ray scattering (SAXS). Disarib-loaded P123 micelle formulation denoted as P123D exhibited a well-defined particle size of approximately 29.2 nm spherical core–shell morphology. Our investigations revealed a notable encapsulation efficiency of 75%, and we observed a biphasic release pattern for the encapsulated Disarib. Furthermore, our cytotoxicity assessment of P123D micelles against mouse breast adenocarcinoma, mouse lymphoma, and human leukemic cell lines showed 40–45% increase in cytotoxicity compared with the administration of Disarib alone in the breast adenocarcinoma cell line. Enhancement in the cytotoxicity of P123D was found to be higher or limited; however, it is important to observe that the encapsulation method significantly enhanced the aqueous solubility of Disarib as it has the best solubility in dimethyl sulfoxide (DMSO) in the unencapsulated state.
format Online
Article
Text
id pubmed-10621013
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-106210132023-11-03 Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential Joy, Reshma Siddiqua, Humaira Sharma, Shivangi Raveendran, Manthra John, Franklin Hassan, Puthusserickal Abdulrahiman Gawali, Santosh L Raghavan, Sathees C. George, Jinu ACS Omega [Image: see text] A chemical inhibitor of antiapoptotic protein, BCL2, known as Disarib, suffers poor solubility in aqueous environments; thereby limiting its potential as a chemotherapeutic agent. To overcome this limitation and enhance the therapeutic efficacy of Disarib, we have employed the encapsulation of this small molecule inhibitor within P123 copolymer matrix. Micelles were synthesized using a thin-film hydration technique, and a comprehensive analysis was undertaken to evaluate the resulting micelle properties, including morphology, particle size, intermolecular interactions, encapsulation efficiency, and in vitro release characteristics. This assessment utilized various physicochemical techniques including UV spectroscopy, FTIR spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), and small-angle X-ray scattering (SAXS). Disarib-loaded P123 micelle formulation denoted as P123D exhibited a well-defined particle size of approximately 29.2 nm spherical core–shell morphology. Our investigations revealed a notable encapsulation efficiency of 75%, and we observed a biphasic release pattern for the encapsulated Disarib. Furthermore, our cytotoxicity assessment of P123D micelles against mouse breast adenocarcinoma, mouse lymphoma, and human leukemic cell lines showed 40–45% increase in cytotoxicity compared with the administration of Disarib alone in the breast adenocarcinoma cell line. Enhancement in the cytotoxicity of P123D was found to be higher or limited; however, it is important to observe that the encapsulation method significantly enhanced the aqueous solubility of Disarib as it has the best solubility in dimethyl sulfoxide (DMSO) in the unencapsulated state. American Chemical Society 2023-10-19 /pmc/articles/PMC10621013/ /pubmed/37929147 http://dx.doi.org/10.1021/acsomega.3c05802 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Joy, Reshma
Siddiqua, Humaira
Sharma, Shivangi
Raveendran, Manthra
John, Franklin
Hassan, Puthusserickal Abdulrahiman
Gawali, Santosh L
Raghavan, Sathees C.
George, Jinu
Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title_full Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title_fullStr Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title_full_unstemmed Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title_short Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
title_sort block copolymer encapsulation of disarib, an inhibitor of bcl2 for improved chemotherapeutic potential
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621013/
https://www.ncbi.nlm.nih.gov/pubmed/37929147
http://dx.doi.org/10.1021/acsomega.3c05802
work_keys_str_mv AT joyreshma blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT siddiquahumaira blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT sharmashivangi blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT raveendranmanthra blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT johnfranklin blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT hassanputhusserickalabdulrahiman blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT gawalisantoshl blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT raghavansatheesc blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential
AT georgejinu blockcopolymerencapsulationofdisaribaninhibitorofbcl2forimprovedchemotherapeuticpotential